Genotype and allele distributions of the APOE in the MetS and non-MetS groups
| Total (992) | Non-MetS group (510) | MetS group (482) | |
|---|---|---|---|
| Genotype | |||
| ε2/2 | 25 (2.5%) | 20 (3.9%) | 5 (1.0%) |
| ε2/3 | 105 (10.6%) | 66 (12.9%) | 39 (8.1%) |
| ε2/4 | 14 (1.4%) | 11 (2.2%) | 3 (0.6%) |
| ε3/3 | 712 (71.8%) | 332 (65.1%) | 380 (78.8%) |
| ε3/4 | 59 (5.9%) | 32 (6.3%) | 27 (5.6%) |
| ε4/4 | 77 (7.8%) | 49 (9.6%) | 28 (5.8%) |
| χ2 Value | – | 29.1 | |
| p Value | – | <0.0001 | |
| Allele | |||
| ε2 | 169 (8.5%) | 117 (11.5%) | 52 (5.4%) |
| ε3 | 1588 (80.0%) | 762 (74.9%) | 826 (85.5%) |
| ε4 | 227 (11.5%) | 139 (13.7%) | 88 (9.1%) |
| χ2 Value | – | 37.7 | |
| p Value | – | <0.0001 | |
Data are shown as n (%). Pearson’s χ2 test was used to analyse the differences of APOE (genotype or allele) between the MetS and non-MetS groups.
MetS, metabolic syndrome.